Angiotensin II induces cardiomyocyte hypertrophy probably through histone deacetylases

Tohoku Journal of Experimental Medicine

Volumn 219, Issue 1, 2009, Pages 17-23

  Lu, Ying ^a   Yang, Shuang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin II; Cardiomyocyte; Histone deacetylase 2; Hypertrophy; Valproic acid

Indexed keywords

ANGIOTENSIN II; HISTONE DEACETYLASE 2; MESSENGER RNA; MYOSIN HEAVY CHAIN BETA; PROTEIN C FOS; VALPROIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC MARKER; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PHARMACOLOGICAL BLOCKING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WISTAR RAT;

ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; CELL ENLARGEMENT; CELL SIZE; CELLS, CULTURED; GENE EXPRESSION; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HYPERTROPHY; MYOCYTES, CARDIAC; MYOSIN HEAVY CHAINS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; VALPROIC ACID;

EID: 70449973282     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.219.17     Document Type: Article

References (25)

1. Curran, T. (1992) Fos and Jun: oncogenic transcription factors. Tohoku J. Exp. Med., 168, 169-174.
2. Frey, N., Katus, H.A., Olson, E.N. & Hill, J.A. (2004) Hypertrophy of the heart: a new therapeutic target? Circulation, 109, 1580-1589.
3. Grozinger, C.M. & Schreiber, S.L. (2002) Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. Chem. Biol., 9, 3-16.
4. Hamamori, Y. & Schneider, M.D. (2003) HATs off to Hop: recruitment of a class I histone deacetylase incriminates a novel transcriptional pathway that opposes cardiac hypertrophy. J. Clin. Invest., 112, 824-826.
5. Hassig, C.A., Fleischer, T.C., Billin, A.N., Schreiber, S.L. & Ayer, D.E. (1997) Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell, 89, 341-347. (Pubitemid 27220878)
6. Kee, H.J., Sohn, I.S., Nam, K.I., Park, J.E., Qian, Y.R., Yin, Z., Ahn, Y., Jeong, M.H., Bang, Y.-J., Kim, N., Kim, J.-K., Kim, K.K., Epstein, J.A. & Kook, H. (2006) Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation, 113, 51-59. (Pubitemid 43958488)
7. Kim, S. & Iwao, H. (1999) Activation of mitogen-activated protein kinases in cardiovascular hypertrophy and remodeling. Jpn. J. pharmacol., 80, 97-102.
8. Kong, Y., Tannous, P., Lu, C., Berenji, K., Rothermel, B.A., Olson, E.N. & Hill, J.A. (2006) Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation, 113, 2579-2588. (Pubitemid 43948006)
9. Kook, H., Lepore, J.J., Gitler, A.D., Lu, M.M., Yung, W.W.M., Mackay, J., Zhou, R., Ferrari, V., Gruber, P. & Epstein, J.A. (2003) Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J. Clin. Invest., 112, 863-871.
10. Krämer, O.H., Zhu, P., Ostendorff, H.P., Golebiewski, M., Tiefenbach, J., Peters, M.A., Brill, B., Groner, B., Bach, I., Heinzel, T. & Göttlicher, M. (2003) The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J., 22, 3411-3420.
11. Laherty, C.D., Yang, W.M., Sun, J.M., Davie, J.R., Seto, E. & Eisenman, R.N. (1997) Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression. Cell, 89, 349-356. (Pubitemid 27220879)
12. Lee, T.M., Linb, M.S. & Chang, N.C. (2007) Inhibition of histone deacetylase on ventricular remodeling in infarcted rats. Am. J. Physiol. Heart Circ. Physiol., 293, H968-H977.
13. Liu, F., Levin, M.D., Petrenko, N.B., Lu, M.M., Wang, T., Yuan, L.J., Stout, A.L., Epstein, J.A. & Patel, V.V. (2008) Histone- deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin. J. Mol. Cell. Cardiol., 45, 715-723.
14. McKinsey, T.A. & Olson, E.N. (2004) Cardiac histone acetylation- therapeutic opportunities abound. Trends Genet., 20, 206-213. (Pubitemid 38369192)
15. McKinsey, T.A. & Olson, E.N. (2006) Regulation of muscle gene expression by histone deacetylases. In Histone Deacetylases, 1st ed., edited by E. Verdin. Humana Press, Totowa, NJ, pp. 107-128.
16. Michaelis, M., Michaelis, U.R., Fleming, I., Suhan, T., Cinatl, J., Blaheta, R.A., Hoffmann, K., Kotchefkov, R., Busse, R., Nau, H. & Cinatl, J. (2004) Valproic acid inhibits angiogenesis in vitro and in vivo. Mol. Pharmacol., 65, 520-527.
17. Pal, S., Yun, R., Datta, A., Lacomis, L., Erdjument-Bromage, H., Kumar, J., Tempst, P. & Sif, S. (2003) mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad. Mol. Cell. Biol, 23, 7475-7487.
18. Shah, B.H. & Catt, K.J. (2003) A central role of EGF receptor transactivation in angiotensin II -induced cardiac hypertrophy. Trends Pharmacol. Sci., 24, 239-244.
19. Simpson, P. (1985) Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of beating through an alpha 1-and beta 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating. Circ. Res., 56, 884-894.
20. Simpson, P. & Savion, S. (1982) Differentiation of rat myocytes in single cell culture with and without proliferating nonmyocardial cells. Circ. Res., 50, 101-116.
21. Townsend, P.A., Crabb, S.J., Davidson, S.M., Johnson, P.W.M., Packham, C. & Ganesan, A. (2007) The bicyclic depsipeptide family of histone deacetylase inhibitors. In Chemical biology: from small molecules to systems biology and drug design, 1st ed., edited by S. Schreiber, T.M. Kapoor & G. Wess. Wiley- VCH, Weinheim, Germany, pp. 693-720.
22. Tsai, S.C. & Seto, E. (2002) Regulation of histone deacetylase 2 by protein kinase CK2. J. Biol. Chem., 277, 31826-31833.
23. Yokota, T., Matsuzaki, Y., Miyazawa, K., Zindy, F., Roussel, M.F. & Sakai, T. (2004) Histone deacetylase inhibitors activate LNK4d gene through Sp1 site in its promoter. Oncogene, 23, 5340-5349. (Pubitemid 39005809)
24. Zeng, Y., Tang, C.M., Yao, Y.L., Yang, W.M. & Seto, E. (1998) Cloning and characterization of the mouse histone deacetylase-2 gene. J. Biol. Chem., 273, 28921-28930.
25. Zhang, C.L., McKinsey, T.A., Chang, S., Antos, C.L., Hill, J.A. & Olson, E.N. (2002) Class II histone deacetylases act as signal- responsive repressors of cardiac hypertrophy. Cell, 110, 479-488. (Pubitemid 35232291)